BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
MYC
,
Fatty acid metabolic process
,
HIV infection
,
Lung
,
Pharmacogenetics
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cyp2c8 protein human
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for cyp2c8 protein human
Explore Curated Studies Results
Literature
Most Relevant Literature
Unintentional combining enzalutamide with a moderate CYP2C8 inhibitor in a patient with metastatic c…
Variability of CYP2C8 Polymorphisms in Three Jordanian Populations: Circassians, Chechens and Jordan…
Rottlerin renders a selective and highly potent CYP2C8 inhibition to impede EET formation for implic…
CYP2C8 rs11572080 and CYP3A4 rs2740574 risk genotypes in paclitaxel-treated premenopausal breast can…
Interplay of UDP-Glucuronosyltransferase and CYP2C8 for CYP2C8 Mediated Drug Oxidation and Its Impac…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrat…
A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple…
Pharmacogenomics of Paclitaxel in Ovarian Cancer
Pharmacogenomics of Paclitaxel in Ovarian Cancer
Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Midazolam, Repaglinide, Dextrometho…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ